3. Leviq. https://www.leqvio.com/ Retrieved on 05, 04, 2023.4. Ballantyne, C. M. et al. Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial. J Am Coll Cardiol. Mar 06, 2023. Epublished DOI: 10.1016/j.jacc.2023.02.018 5. Goldstein...
WO2023023245A1 Compounds for treating conditions related to pcsk9 activity 2. https://www.businesswire.com/news/home/20230306005288/en/Merck%E2%80%99s-MK-0616-an-Investigational-Oral-PCSK9-Inhibitor-Significantly-Reduced-LDL-C-in-Patients-with-Hypercholesterolemia-in-Phase-2b-Study?utm_campaign=sha...